Works matching IS 20479158 AND DT 2024
Results: 68
SARS-CoV-2 membrane protein induces neurodegeneration via affecting Golgi-mitochondria interaction.
- Published in:
- Translational Neurodegeneration, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40035-024-00458-1
- By:
- Publication type:
- Article
N-terminus α-synuclein detection reveals new and more diverse aggregate morphologies in multiple system atrophy and Parkinson's disease.
- Published in:
- Translational Neurodegeneration, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40035-024-00456-3
- By:
- Publication type:
- Article
Endosomal traffic disorders: a driving force behind neurodegenerative diseases.
- Published in:
- Translational Neurodegeneration, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40035-024-00460-7
- By:
- Publication type:
- Article
Inflammasomes in neurodegenerative diseases.
- Published in:
- Translational Neurodegeneration, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40035-024-00459-0
- By:
- Publication type:
- Article
CD2AP deficiency aggravates Alzheimer's disease phenotypes and pathology through p38 MAPK activation.
- Published in:
- Translational Neurodegeneration, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40035-024-00454-5
- By:
- Publication type:
- Article
Recombinant SMN protein synergizes with spinal muscular atrophy therapy to counteract pathological motor neuron phenotypes.
- Published in:
- Translational Neurodegeneration, 2024, v. 13, p. 1, doi. 10.1186/s40035-024-00455-4
- By:
- Publication type:
- Article
Recombinant SMN protein synergizes with spinal muscular atrophy therapy to counteract pathological motor neuron phenotypes.
- Published in:
- Translational Neurodegeneration, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40035-024-00455-4
- By:
- Publication type:
- Article
Astrocytes contribute to toll-like receptor 2-mediated neurodegeneration and alpha-synuclein pathology in a human midbrain Parkinson's model.
- Published in:
- Translational Neurodegeneration, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40035-024-00448-3
- By:
- Publication type:
- Article
Cellular senescence as a key contributor to secondary neurodegeneration in traumatic brain injury and stroke.
- Published in:
- Translational Neurodegeneration, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40035-024-00457-2
- By:
- Publication type:
- Article
Extracellular vesicles: biological mechanisms and emerging therapeutic opportunities in neurodegenerative diseases.
- Published in:
- Translational Neurodegeneration, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40035-024-00453-6
- By:
- Publication type:
- Article
Enhanced prefrontal nicotinic signaling as evidence of active compensation in Alzheimer's disease models.
- Published in:
- Translational Neurodegeneration, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40035-024-00452-7
- By:
- Publication type:
- Article
Aquaporin-4 as a cerebrospinal fluid biomarker of Alzheimer's disease.
- Published in:
- Translational Neurodegeneration, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40035-024-00451-8
- By:
- Publication type:
- Article
α-Synuclein seeding amplification assays for diagnosing synucleinopathies: an innovative tool in clinical implementation.
- Published in:
- Translational Neurodegeneration, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40035-024-00449-2
- By:
- Publication type:
- Article
Cellular senescence in Alzheimer's disease: from physiology to pathology.
- Published in:
- Translational Neurodegeneration, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40035-024-00447-4
- By:
- Publication type:
- Article
Critical role of ROCK1 in AD pathogenesis via controlling lysosomal biogenesis and acidification.
- Published in:
- Translational Neurodegeneration, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40035-024-00442-9
- By:
- Publication type:
- Article
A tumorigenicity evaluation platform for cell therapies based on brain organoids.
- Published in:
- Translational Neurodegeneration, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40035-024-00446-5
- By:
- Publication type:
- Article
TRPV1 alleviates APOE4-dependent microglial antigen presentation and T cell infiltration in Alzheimer's disease.
- Published in:
- Translational Neurodegeneration, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40035-024-00445-6
- By:
- Publication type:
- Article
Ultrasensitive detection of TDP-43 and amyloid-β protein aggregates using micelle-assisted seed amplification assay.
- Published in:
- Translational Neurodegeneration, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40035-024-00444-7
- By:
- Publication type:
- Article
Elevated plasma and CSF neurofilament light chain concentrations are stabilized in response to mutant huntingtin lowering in the brains of Huntington's disease mice.
- Published in:
- Translational Neurodegeneration, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40035-024-00443-8
- By:
- Publication type:
- Article
GCN2 inhibition reduces mutant SOD1 clustering and toxicity and delays disease progression in an amyotrophic lateral sclerosis mouse model.
- Published in:
- Translational Neurodegeneration, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40035-024-00441-w
- By:
- Publication type:
- Article
Clinical, mechanistic, biomarker, and therapeutic advances in GBA1-associated Parkinson's disease.
- Published in:
- Translational Neurodegeneration, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40035-024-00437-6
- By:
- Publication type:
- Article
The microglial P2Y<sub>6</sub> receptor as a therapeutic target for neurodegenerative diseases.
- Published in:
- Translational Neurodegeneration, 2024, p. 1, doi. 10.1186/s40035-024-00438-5
- By:
- Publication type:
- Article
Neurodegenerative disorders, metabolic icebergs, and mitohormesis.
- Published in:
- Translational Neurodegeneration, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40035-024-00435-8
- By:
- Publication type:
- Article
Updates in Alzheimer's disease: from basic research to diagnosis and therapies.
- Published in:
- Translational Neurodegeneration, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40035-024-00432-x
- By:
- Publication type:
- Article
A novel plasma p-tau181 assay as a specific biomarker of tau pathology in Alzheimer's disease.
- Published in:
- Translational Neurodegeneration, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40035-024-00439-4
- By:
- Publication type:
- Article
Hybrid nanostructures for neurodegenerative disease theranostics: the art in the combination of biomembrane and non-biomembrane nanostructures.
- Published in:
- Translational Neurodegeneration, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40035-024-00436-7
- By:
- Publication type:
- Article
Trajectory of brain-derived amyloid beta in Alzheimer's disease: where is it coming from and where is it going?
- Published in:
- Translational Neurodegeneration, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40035-024-00434-9
- By:
- Publication type:
- Article
SGLT2 inhibitors: a novel therapy for cognitive impairment via multifaceted effects on the nervous system.
- Published in:
- Translational Neurodegeneration, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40035-024-00431-y
- By:
- Publication type:
- Article
Tau in neurodegenerative diseases: molecular mechanisms, biomarkers, and therapeutic strategies.
- Published in:
- Translational Neurodegeneration, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40035-024-00429-6
- By:
- Publication type:
- Article
Neuronal double-stranded DNA accumulation induced by DNase II deficiency drives tau phosphorylation and neurodegeneration.
- Published in:
- Translational Neurodegeneration, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40035-024-00427-8
- By:
- Publication type:
- Article
Linking APOE4/4 genotype to microglial lipid droplets and neurotoxicity in Alzheimer's disease.
- Published in:
- Translational Neurodegeneration, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40035-024-00433-w
- By:
- Publication type:
- Article
Blood–brain barrier alterations and their impact on Parkinson's disease pathogenesis and therapy.
- Published in:
- Translational Neurodegeneration, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40035-024-00430-z
- By:
- Publication type:
- Article
Can exercise benefits be harnessed with drugs? A new way to combat neurodegenerative diseases by boosting neurogenesis.
- Published in:
- Translational Neurodegeneration, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40035-024-00428-7
- By:
- Publication type:
- Article
Ultrasensitive detection of aggregated α-synuclein using quiescent seed amplification assay for the diagnosis of Parkinson’s disease.
- Published in:
- Translational Neurodegeneration, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40035-024-00426-9
- By:
- Publication type:
- Article
Dorsal raphe nucleus–hippocampus serotonergic circuit underlies the depressive and cognitive impairments in 5×FAD male mice.
- Published in:
- Translational Neurodegeneration, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40035-024-00425-w
- By:
- Publication type:
- Article
Transcranial alternating current stimulation (tACS) at gamma frequency: an up-and-coming tool to modify the progression of Alzheimer's Disease.
- Published in:
- Translational Neurodegeneration, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40035-024-00423-y
- By:
- Publication type:
- Article
The relation of synaptic biomarkers with Aβ, tau, glial activation, and neurodegeneration in Alzheimer's disease.
- Published in:
- Translational Neurodegeneration, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40035-024-00420-1
- By:
- Publication type:
- Article
DOPA-decarboxylase is elevated in CSF, but not plasma, in prodromal and de novo Parkinson's disease.
- Published in:
- Translational Neurodegeneration, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40035-024-00421-0
- By:
- Publication type:
- Article
Retraction Note: Asiaticoside, a trisaccaride triterpene induces biochemical and molecular variations in brain of mice with parkinsonism.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
In vivo diagnosis of TDP-43 proteinopathies: in search of biomarkers of clinical use.
- Published in:
- Translational Neurodegeneration, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40035-024-00419-8
- By:
- Publication type:
- Article
Variability in SOD1-associated amyotrophic lateral sclerosis: geographic patterns, clinical heterogeneity, molecular alterations, and therapeutic implications.
- Published in:
- Translational Neurodegeneration, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40035-024-00416-x
- By:
- Publication type:
- Article
Central nervous system-derived extracellular vesicles: the next generation of neural circulating biomarkers?
- Published in:
- Translational Neurodegeneration, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40035-024-00418-9
- By:
- Publication type:
- Article
CSF biomarkers of reactive glial cells are associated with blood–brain barrier leakage and white matter lesions.
- Published in:
- Translational Neurodegeneration, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40035-024-00422-z
- By:
- Publication type:
- Article
Considerations for biomarker strategies in clinical trials investigating tau-targeting therapeutics for Alzheimer's disease.
- Published in:
- Translational Neurodegeneration, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40035-024-00417-w
- By:
- Publication type:
- Article
Agomirs upregulating carboxypeptidase E expression rescue hippocampal neurogenesis and memory deficits in Alzheimer's disease.
- Published in:
- Translational Neurodegeneration, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40035-024-00414-z
- By:
- Publication type:
- Article
Focusing on mitochondria in the brain: from biology to therapeutics.
- Published in:
- Translational Neurodegeneration, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40035-024-00409-w
- By:
- Publication type:
- Article
The role of the brain renin-angiotensin system in Parkinson´s disease.
- Published in:
- Translational Neurodegeneration, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40035-024-00410-3
- By:
- Publication type:
- Article
CRISPR base editing-mediated correction of a tau mutation rescues cognitive decline in a mouse model of tauopathy.
- Published in:
- Translational Neurodegeneration, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40035-024-00415-y
- By:
- Publication type:
- Article
Stathmin 2 is a potential treatment target for TDP-43 proteinopathy in amyotrophic lateral sclerosis.
- Published in:
- Translational Neurodegeneration, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40035-024-00413-0
- By:
- Publication type:
- Article
Pathophysiological subtypes of mild cognitive impairment due to Alzheimer's disease identified by CSF proteomics.
- Published in:
- Translational Neurodegeneration, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40035-024-00412-1
- By:
- Publication type:
- Article